| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP, Chief Commercial Officer | Chief Commercial Officer | Chief Commercial Officer
1 company
Heerma Peter serves as an EVP, Chief Commercial Officer at TVTX. Across recent SEC filings that breaks down to 0 buys and 35 sells. Those positions are worth an estimated $7.6M at current prices.
Historically, Heerma Peter's trades have earned a middling insider score of 53/100 across 21 rated trades. Over a 12-month horizon, 31.3% of those trades were profitable, with an average 12-month return of -26.6%.
The biggest single holding is TVTX (~$7.6M) as EVP, Chief Commercial Officer. The recent filings there lean toward selling, a net 359,908 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 22, 2025 | TVTX Travere Therapeutics, Inc. | Chief Commercial Officer | Sell | 1,584 | $18.94 | $30,002.23 | -1.5% | -18.4% | +52.8% | |
| Sep 9, 2024 | TVTX Travere Therapeutics, Inc. | Chief Commercial Officer | Sell | 2,191 | $11.52 | $25,240.32 | -2.0% | +46.0% | +68.3% | |
| Feb 1, 2024 | TVTX Travere Therapeutics, Inc. | Chief Commercial Officer | Sell | 4,195 | $8.53 | $35,788.80 | -4.0% | -30.2% | +137.9% | |
| Jan 23, 2024 | TVTX Travere Therapeutics, Inc. | Chief Commercial Officer | Sell | 1,559 | $9.07 | $14,137.64 | -1.9% | -37.0% | +109.5% | |
| Oct 3, 2023 | TVTX Travere Therapeutics, Inc. | Chief Commercial Officer | Sell | 3,091 | $8.25 | $25,504.15 | -3.7% | +11.8% | +62.2% | |
| Feb 1, 2023 | TVTX Travere Therapeutics, Inc. | Chief Commercial Officer | Sell | 1,779 | $21.75 | $38,696.81 | -2.1% | -29.2% | -61.1% | |
| Jan 24, 2023 | TVTX Travere Therapeutics, Inc. | Chief Commercial Officer | Sell | 1,550 | $21.90 | $33,951.82 | -2.4% | -2.9% | -58.3% | |
| Oct 4, 2022 | TVTX Travere Therapeutics, Inc. | Chief Commercial Officer | Sell | 3,042 | $25.68 | $78,118.56 | -4.5% | -20.6% | -69.8% | |
| Jan 31, 2022 | TVTX Travere Therapeutics, Inc. | Chief Commercial Officer | Sell | 1,125 | $27.40 | $30,825.00 | -1.6% | -6.4% | -18.5% | |
| Jan 24, 2022 | TVTX Travere Therapeutics, Inc. | Chief Commercial Officer | Sell | 1,875 | $24.98 | $46,837.50 | -3.1% | +9.9% | -16.2% |